NCT04590365 Iota-carrageenan nasal spray COVID-19 prophylaxis for healthcare professionals (ICE-COVID) Coldamaris plus nasal and throat spray (Iota-carrageenan 0.12% in 0.5% saline) recruiting – UK Furthermore, a randomized double-blind trial involving 153 children was conducted between 2009 and ...
A within-trial economic evaluation will be undertaken, with effects expressed as quality-adjusted life years.This is a single-centre, phase III, double-blind, randomised placebo-controlled clinical trial to assess whether carrageenan nasal and throat spray reduces the risk of development and severity...
NCT01944631 Iota-carrageenan nasal spray in common cold Four times daily for 4–10 days, nasal spray containing 1.20 g/l iota-carrageenan in saline completed 4 UK NCT04533906 Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Vir...
Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: The ICICC trial. Respir. Res. 2015, 16, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version] Matloub, A.A.; Elsouda, S.S.M.; El-Senousy, W.M.; Hamed...